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Double-Stranded Break Can Be Repaired by 
Single-Stranded Oligonucleotides via the ATM/ATR 
Pathway in Mammalian Cells
ZAI WANG,1 ZHONG-JUN ZHOU,1 DE-PEI LIU,2 and JIAN-DONG HUANG1
ABSTRACT
Single-stranded oligonucleotide (SSO)-mediated gene modification is a newly developed tool for site-
specific gene repair in mammalian cells; however, the corrected cells always show G2/M arrest and
cannot divide to form colonies. This phenomenon and the unclear mechanism seriously challenge the
future application of this technique. In this study, we developed an efficient SSO-mediated DNA re-
pair system based on double-stranded break (DSB) induction. We generated a mutant EGFP gene
with insertions of 24 bp to 1.6 kb in length as a reporter integrated in mammalian cell lines. SSOs
were successfully used to delete the insertion fragments upon DSB induction at a site near the inser-
tion. We demonstrated that this process is dependent on the ATM/ATR pathway. Importantly, re-
paired cell clones were viable. Effects of deletion length, SSO length, strand bias, and SSO modifica-
tion on gene repair frequency were also investigated.
INTRODUCTION
SINGLE-STRANDED OLIGONUCLEOTIDE (SSO)-mediatedrepair is able to introduce targeted genetic alterations
into mammalian cells (Igoucheva et al. 2001; Liu et al.
2001; Lu et al., 2003). Up to now, the repair process has
not been fully understood. Our previous study has shown
that SSO may anneal to its homologous target during
DNA replication (Wu et al., 2005), and the recombina-
tion used pathways other than the ATM/ATR pathway
(Wang et al. 2006). However, the corrected cells always
show G2/M arrest and cannot divide to form colonies
(Olsen et al., 2005a). This serious problem and the un-
clear reason are hurdles to the future application of this
technique.
In yeast, SSOs are able to mediate long fragment dele-
tion, and very high efficiencies have been achieved upon
site-specific double-stranded break (DSB) induction
(Storici et al. 2003). Similarly, in mammalian cells, a re-
cent report showed that SSOs can modify chromosomal
gene in the presence of a DSB and generate viable clones
(Radecke et al., 2006). However, which recombination
pathway the SSOs utilize is not clear. Furthermore, for
future applications of this method, there are several pa-
rameters that need to be optimized to achieve the highest
efficiency.
For this purpose, we used a series of mutant EGFP
genes harboring insertions of 24 bp to 1.6 kb in length as
a reporter system. We showed SSOs can successfully
delete the inserted fragment upon DSB induction, and
generate viable cell clones after chromosomal repair. We
demonstrated that this process depends on the ATM/
ATR pathway. Effects of parameters related to recombi-
nation efficiency were also tested.
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MATERIALS AND METHODS
Plasmids
To generate pcSceGFP-24, the first fragment of
SceGFP sequence was amplified from pDRGFP (Pierce
et al., 1999) using primers: 5-CGGGATCCGCCACC-
ATGGTGAGCAA-3 (forward), and 5-GCGAATTCA-
TTACCCTGTTATCCCTAGC-3 (reverse), and then di-
gested with BamHI and EcoRI. Underlined nucleotides
are the recognition site of I-SceI, which also introduces
two in-frame stop codons. The second fragment of
SceGFP was amplified from pEGFP-C1 (Clontech, Palo
Alto, CA) using primers: 5-GCGAATTCGAGGGC-
GAGGGCGATGC-3 (forward), and 5-ACGCGTCG-
ACTTACTTGTACAGCTCGTCCATG-3 (reverse),
and then digested with EcoRI and SalI. The two frag-
ments were ligated to pcDNA3.1() (Invitrogen, Carls-
bad, CA) digested with BamHI and XhoI.
To generate pcSceGFP-300 and pcSceGFP-1.6k, an ir-
relevant 300-bp or 1.6-kb fragment of the lacZ gene was
amplified from pcDNA3.1/His/lacZ (Invitrogen) and lig-
ated into the EcoRI site of pcSceGFP-24.
To generate pcEGFP, the EGFP gene was amplified
from pEGFP-C1 using primers: 5-CGGGATCCGC-
CACCATGGTGAGCAA-3 (forward), and 5-ACGCG-
TCGACTTACTTGTACAGCTCGTCCATG-3 (reverse).
The PCR fragment was digested with BamHI and SalI,
and was ligated to pcDNA3.1() (Invitrogen) digested
with BamHI and XhoI.
SSOs
SSOs were designed to have equal lengths to homolo-
gous sequences flanking the insertion fragments in pc-
SceGFP-24/300/1.6k. SSOs termed with an initiating
“M” indicated the presence of six phosphorothioate-
modified nucleotides at each end. SSOs termed with an
ending “s” or “as” indicated they were sense or antisense
according to the EGFP coding sequence. An irrelevant
SSO E6 was used as a control. For complete SSOs se-
quences, please refer to the Supplementary Data.
Cell lines
To set up HEK-24/300/1.6k cells or HeLa-24/300/1.6k
cells, pcSceGFP-24/300/1.6k plasmids were linearized
with PvuI and transfected into HEK293 or HeLa cells, re-
spectively. The cells were cultured for 48 hours and then
passaged at 50,000 cells per 10-cm dish for G418 (500
g/mL) selection.
siRNAs
We transiently transfected the following siRNA du-
plexes into HEK-24 cells to knock down the targeted
genes expression (leading strands): siATM, 5-AACAT-
ACTACTCAAAGACATTdTdT-3 (Andreassen et al.,
2004); siATR, 5-AAGACGGTGTGCTCATGCGGC-
dTdT-3 (Shiotani et al., 2006); and siDNA-PKcs, 5-
AGGGCCAAGCTGTCACTCTdTdT-3 (Feng et al.,
2004). The control siRNA was selected as a nontarget 
sequence: 5-AGTACGAGAACCTGAAGTAdTdT-3.
All of the siRNA duplexes were synthesized by Dharma-
con (Boulder, CO). Cells in 24-well plate were trans-
fected with 40 ng siRNA duplexes by lipofectamine 2000
(Invitrogen). To examine the gene-silencing effect, cells
were collected at 24 hours or 48 hours after transfection
and subjected to 5% SDS-PAGE. For immunobloting,
anti-ATM, anti-ATR (both are gifts from Dr. Junjie
Chen) or anti-DNA-PKcs (Lab Vision, Freemont, CA)
was used as the first antibody. To ensure the equal load-
ing, anti--tubulin (Sigma, St. Louis, MO) was used as
an internal control.
Deletion assays
Cells were seeded to 70% to 80% confluence in 24-
well plates and grown for 24 hours before transfection.
For deletion assays on plasmid, SSOs (0.15 g) and pc-
SceGFPs (0.75 g) with or without I-SceI (New England
Biolabs, Beverly, MA) linearization were cotransfected
into cells. For deletion assay on genomic DNA, SSOs
(0.15 g) with or without I-SceI expression vector (0.75
g), and with or without siRNAs (40 ng) were trans-
fected into reporter cell lines. For each well, 2 L Lipo-
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FIG. 1. Illustration of the SSO-mediated deletion system. EGFP expression was driven by the CMV promoter (arrow). A 24-bp,
300-bp, or 1.6-kb fragment was inserted into 96 locus after start codon ATG within EGFP gene (gray). At the beginning of the
insertion, an I-SceI recognition site was introduced, which also introduced two in-frame stop codons. A DSB would be induced at
this site upon I-SceI encoding plasmid transfection. SSOs designed to make deletions had equal length of homologous flanking in
the inserted fragments. (A) Observation of SSO-mediated deletion on pSceGFP-24 in HeLa cells under a fluorescent microscope.
The left panel presents only pSceGFP-24-transfected cells. The right panel presents pSceGFP-24- and SSO M90as-cotransfected
cells. (B) The efficiency of the deletion assay can be measured by FACS. After SSO-mediated deletion on pSceGFP-24 in Huh7
cells, the cells were trypsinized and subjected to FACS analysis. The left panel presents only pSceGFP-24-transfected cells. The
right panel presents pSceGFP-24- and SSO M90as-cotransfected cells. (C) Observation of SSO-mediated deletion HEK-24 cells
under fluorescent microscope. The left panel presents control SSO E6-transfected cells. The right panel presents SSO M90as-
transfected cells.
FIG. 1.
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fectamine2000 (Invitrogen) was used according to the
protocol. Different drugs, thymidine (2 mM), caffeine (3
mM), pentoxifylline (3 mM), and vanillin (1 mM) (all
from Sigma) were added to the culture medium before
transfection where indicated.
For deletion assay using double-stranded DNA (ds-
DNA) as a donor, a PCR fragment amplified from
pcEGFP using primers TGGGCGTGGATAGCGGTTT
(forward) and CGGGATCCCTTGAAGTTCACCTTG-
ATGC (reverse) was transfected into the cells as a re-
placement of SSOs.
Microscopy
Cells after gene repair were detected using an inverted
fluorescence microscope (Zeiss Axiovert 135, Thorn-
wood, NY).
FACS analysis
To measure EGFP repair efficiency, cells were
trypsinized 72 hours posttransfection, washed with
PBS, and directly subjected to flow cytometry (Beck-
man Coulter, Fullerton, CA) using a 488-nm argon-ion
laser. For each analysis, 20,000 cells were counted.
Single cell population was ensured by FS/SS gating
during analysis.
RESULTS
SSO can generate deletions on episomal and ge-
nomic DNA without DSB induction
To investigate whether SSOs can generate DNA dele-
tion in mammalian cells, we constructed three EGFP re-
porters with a 24-bp, 300-bp, or 1.6-kb insertion called
pcSceGFP-24/300/1.6k, respectively. At the beginning
of the insertion, an I-SceI endonuclease recognition site
was included that also introduced two in-frame stop
codons to terminate EGFP translation (Fig. 1A). Thus,
EGFP expression can only be achieved if the inserted
fragment is removed and the EGFP coding sequence was
recovered.
We first examined whether SSOs can generate dele-
tions on a plasmid. We transfected pcSceGFP-24 alone
or together with SSO M90as into HeLa cells. Seventy-
two hours after transfection, cells were observed under a
fluorescent microscope. We found that little cells are
green in pcSceGFP-transfected cells, while green fluo-
rescence cells can be observed in pcSceGFP-24 and
M90as cotransfected cells (Fig. 1B), indicating deletion
of the insertion fragment occurred. We also tested
HEK293 cells and Huh7 cells and observed deletion
events in all of these cell lines. FACS analysis showed
the deletion efficiency was about 0.2%, 0.1%, and up to
0.6% in HeLa, HEK293, and Huh7 cells, respectively,
while the control group with only pcSceGFP-24 transfec-
tion showed 0.01% of the cells gave out weak green
fluorescence (Fig. 1C). As the transgene expression level
was quite high in Huh7 cells as measured by pEGFP-C1
expression (data not shown), the higher deletion effi-
ciency observed in Huh7 cells may be due to a higher
read-out efficiency, as FACS analysis is based on fluo-
rescent protein expression level.
Next, we examined whether the SSOs can generate
deletions in genomic DNA in mammalian cells. We
transfected pcSceGFP-24/300/1.6k into HeLa or
HEK293 cells and obtained stable cell lines with chro-
mosomal integration of EGFP reporters after drug selec-
tion. Without SSO transfection, or with control SSO E6
transfection, no green cells can be observed in HEK-24
cells, showing a clear background (Fig. 1D). We trans-
fected SSO M90as into HEK-24 cells, and after 72 hours,
a small number of green cells were observed under a flu-
orescent microscope (Fig. 1D), indicating the deletion
occurred at the genomic DNA level. However, FACS
analysis showed the efficiency was only 0.01% (data
not shown), and the efficiency was not stable among in-
dependent experiments. Despite the low efficiency, we
found that the repaired green cells were unable to divide
and remained as single cells (Fig. 1D). This phenomenon
is similar to that we observed in cells after gene repair by
SSO-mediated single nucleotide substitution, in which
the repaired cells were arrested in the G2/M phase (Wang
et al., 2006).
DNA DSB can be repaired by SSOs and serves
as a stimulation signal
DSBs in human cell genome can be repaired by two
major pathways. It is primarily repaired by a nonhomolo-
gous end joining (NHEJ) pathway. NHEJ directly ligates
two DNA ends that may lead to short deletions, and is
therefore potentially mutagenic. DNA-dependent protein
kinase (DNA-PK) functions in NHEJ, which comprises
the DNA end-binding heterodimer Ku70/Ku80 and the
catalytic subunit DNA-PKcs (Jackson, 2002). Instead of
NHEJ, human cells may use homologous recombination
(HR) to repair DSBs, which utilizes an homologous se-
quence from an undamaged chromatid, and is thought to
be potentially correct. In homologous recombination re-
pair (HRR), ATM/ATR plays a central role, which serve
as sensor proteins to passage the DNA damage signal to
the downstream effectors (reviewed in Shiloh, 2003;
Bartek et al., 2004).
To investigate the role of DSB in SSO-mediated DNA
deletion, we transfected the I-SceI expression vector into
HEK-24 cells to generate a DSB at its recognition site
about 96 bp downstream of the EGFP start codon, and
studied the deletion efficiency with SSO transfection. In
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the control experiment, I-SceI expression alone did not
lead to functional EGFP expression as measured by
FACS analysis or microscopy. It is most likely that DSBs
are repaired by the NHEJ pathway without regenerating a
functional EGFP gene; our deletion reporter system
showed an extremely low background. Then we cotrans-
fected HEK-24 cells with SSOs and I-SceI expression
vector. Seventy-two hours later, up to 0.25% of the cells
were repaired as measured by FACS, a 20-fold in-
crease than in cells without DSB induction (Table 1).
We also tested whether DSB can stimulate deletion re-
pair on plasmid DNA. We performed the deletion assay
on I-SceI linearized or unlinearized plasmids in HEK293
cells. As shown in Table 1, the deletion efficiency was
about 0.2% at the highest for nonlinearized pSceGFP-24.
However, for linearized pSceGFP-24, the efficiency was
about 10% in SSO M90as transfected cells. In other com-
parable groups, plasmid linearization consistently re-
sulted in 10- to 100-fold increases in efficiency. Taken
together, these data indicate that DSB can stimulate both
genomic and plasmid repair by SSO in mammalian cells.
Cells remained viable after DSB-induced 
SSO-mediated deletion repair on genomic DNA
As it is known that cells after DSB-induced HRR can
undergo the normal cell cycle (Wang et al., 2006), we in-
vestigated the impact of DSB-induced SSO-mediated
deletion repair. We performed deletion assays in HEK-24
cells with DSB induction. As a result, we found that 
the repaired green cells were able to divide and form
colonies (Fig. 2A).
We isolated the green cells by fluorescent sorting after
expansion, and extracted genomic DNA from the cells
for sequencing. We used PCR to amplify the EGFP gene
and used a reverse primer for sequencing. As shown in
Figure 2B, the artificial insertion was successfully re-
moved, that is, the genomic DNA from the green cells
was identical to the EGFP sequence. A weak signal of a
second DNA sequence was also observed in the sequenc-
ing result, identical to the pcSceGFP-24 sequence. This
may be due to heterogeneity in the sorted cells, as the
sorted cells were only 80% fluorescent positive as ana-
lyzed by FACS (data not shown).
DSB-induced SSO-mediated deletion repair relies
on the ATM/ATR pathway
By using two well-characterized ATM/ATR inhibitors
caffeine (Sarkaria et al., 1999) and pentoxifylline (Bohm
et al., 2003), we showed that the ATM/ATR pathway
strongly regulates DSB-induced HRR in reporter cell
lines; however, it is dispensable for SSO-mediated gene
repair in the absence of DSB (Wang et al., 2006). Here,
we used the same approach to study whether DSB-in-
duced SSO-mediated deletion repair depends on the
ATM/ATR pathway as is the case for dsDNA-mediated
repair. We used a 722-bp PCR fragment spanning the
DSB site as the donor dsDNA. After transfection of this
dsDNA fragment into HEK-24 cells, there was no gene
repair (fluorescence) without DSB induction, but there
were 0.6% EGFP-positive cells upon DSB induction.
In a separate experiment, M90as was used as SSO donor.
The deletion efficiency is about 0.2%. Different inhibi-
tors were added prior to transfection and maintained for
72 hours before flow cytometry analysis.
As shown in Figure 3A and B, two ATM/ATR inhibi-
tors caffeine and pentoxifylline could inhibit both SSO-
and dsDNA-mediated deletion repairs by about 80%. As
a control, vanillin (Durant and Karran, 2003), an inhibi-
tor of DNA-PK in the NHEJ pathway, only caused about
30% reduction of efficiency in both SSO- and dsDNA-
mediated deletion repair. All these drugs had little effect
on transfection efficiency as inspected by pEGFP-C1
(Clontech) transfection (data not shown). These data in-
dicate that DSB-induced SSO-mediated deletion repair
may utilize the ATM/ATR pathway, which is similar to
dsDNA-mediated HRR.
To exclude the side effects of these chemicals and fur-
ther verify the role of ATM/ATR in the repair process,
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TABLE 1. DELETION EFFICIENCY
Efficiency (%)
pSceGFP-24  SSOs HEK-24  SSOs
I-SceI    
M90s 0.09 (0.01) 12.38 (1.11) 0.00 (0.00) 0.05 (0.02)
M90as 0.20 (0.02) 10.40 (1.24) 0.01 (0.01) 0.25 (0.03)
For deletion assay on episomal DNA, HEK293 cells were transfected with SSO and
pSceGFP-24 with or without linearization. For deletion assay on genomic DNA,
HEK-24 cells were transfected with SSOs alone or cotransfected with I-SceI expres-
sion vector. Data were derived from three independent experiments.
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we next used siRNA duplexes, which target ATM, ATR,
or DNA-PKcs to silence the corresponding gene expres-
sion. Inspected by immonubloting, we found that 24
hours after siRNAs transfection, the targeted gene ex-
pression started to decrease (data not shown), and we can
observe about 70% reduction of the protein amount at 48
hours posttransfection (Suppl. Fig. 1). In the deletion as-
says, we cotransfected siRNAs and I-SceI expression
vectors, together with SSO M90as or dsDNA donors. Re-
pair efficiency was measured at 72 hours posttransfec-
tion. By cotransfecting siRNAs and pEGFP-C1, we
found that transfection of siRNAs did not affect the trans-
fection efficiency or the EGFP expression level (data not
shown). However, transfection of siRNAs had a nonspe-
cific inhibition effect on repair efficiency, as exhibited by
control siRNA (Fig. 3C and D). Compared to the control
siRNA, siATM and siATR both inhibited repair effi-
ciency on SSO- and dsDNA-mediated deletion repair. On
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FIG. 3. Deletion in genomic DNA mediated by SSOs or dsDNAs upon DSB induction share similar mechanism. (A,B) HEK-24
cells were treated with the ATM/ATR inhibitors caffeine or pentoxifylline, or with the DNA-PK inhibitor vanillin before cotrans-
fection of I-SceI expression vectors and donor DNA as SSO M90as (A) or dsDNA donors (B). The control experiment () indi-
cated that no inhibitor was added before transfection. (C,D) HEK-24 cells were cotransfected with siRNAs and I-SceI expression
vectors, together with SSO M90as (C) or dsDNA fragments (D). The control experiment () indicated that no siRNA was co-
transfected with I-SceI expression vectors and donor DNAs. Data were derived from three independent experiments.
the contrary, the siDNA-PKcs even increased the repair
efficiency with both type of donor DNAs (Fig. 3C and
D). This result was reasonable because as HR and NHEJ
pathways are two major pathways for DSB repair, inhibi-
tion of the NHEJ pathway may provide more repair op-
portunity for HR machinery. Taken together, we verified
that ATM/ATR pathway played a central role in DSB-
induced deletion repair with donor DNA as SSOs or 
dsDNAs.
Evaluation of several parameters in 
SSO-mediated deletion
In SSO-mediated repair in mammalian cells, several
parameters such as SSO modification, SSO length, and
strand bias are known to influence the repair efficiency
(review in Parekh-Olmedo et al., 2005). Here, we investi-
gate these factors in SSO-mediated deletion, and also in-
vestigate the influence of the length of DNA sequence to
be deleted.
To test the relationship between deletion efficiency
and deletion length, we designed three different lengths
of insertion fragment to be deleted by SSOs: 24 bp, 300
bp, and 1.6 kb. We observed that on both the plasmid and
genome, deletion of the longer fragment proved to be less
efficient. On a nonlinearized plasmid, deletion of 24 bp
was twofold more efficient than a deletion of 300 bp, and
about fourfold more efficient than a deletion of 1.6 kb
(Fig. 4A). On linearized plasmids, a similar relationship
between deletion efficiency and deletion length was 
observed (Fig. 4B). For genomic deletion in HeLa-
24/300/1.6k cells, a low background was observed in
HeLa-300/1.6k cells, for which the reason was not clear.
SSOs could generate deletion of the 24-bp insertion with
the efficiency up to 0.18%. However, for the 300-bp or
1.6-kb fragments deletion, SSOs can only generate up to
0.01% repair events compared to the background (Fig.
4C). In HEK-24/300/1.6kb cells with DSB induction, the
SSO generated deletion of 24 bp in HEK-24 cells had the
highest efficiency. Deletion efficiency for the 300-bp in-
sertion was fivefold lower comparatively, and there was
no detectable deletion for the 1.6-kb insertion (Fig. 4D).
To test the effect of different SSO lengths on deletion
efficiency, we used 30-, 60-, or 90-mer SSOs in the dele-
WANG ET AL.28
FIG. 4. Effect of deletion length on SSO-mediated deletion efficiency. Factors of sense (empty) or antisense (filled) of SSO were
also tested. (A) Deletion of different lengths of the fragment (24 bp, 300 bp, or 1.6 kb) on unlinearized plasmids in Huh7 cells. (B)
Deletion of 24 bp, 300 bp, or 1.6 kb fragments on linearized plasmids in Huh7 cells. (C) Deletion of different lengths of fragment
in HeLa-24 (white), HeLa-300 (gray), or HeLa-1.6k (black) cells with DSB induction. (D) Deletion of different lengths of frag-
ments in HEK-24 (white), HEK-300 (gray), or HEK-1.6k (black) cells with DSB induction. Control experiments included no SSO
transfected cells (), or unrelated SSO E6-transfected cells. Data were derived from three independent experiments.
tion assay. Longer SSOs always showed a higher effi-
ciency at both the episome and genome level. 90-mer
SSO was the most efficient for the SSO tested, followed
by 60-mer SSO, and finally the 30-mer SSO, which
showed the lowest efficiency (Fig. 5A and B). This
clearly indicates that the deletion efficiency is positively
related to the length of homologous sequence.
To test whether there is strand bias in SSO-mediated
deletions, we used sense or antisense SSO to make dele-
tions on plasmids or genomic DNA. Previously we
showed that only antisense SSOs can make single nucle-
otide substitutions in genomic DNA, indicating a strong
strand bias (Yin et al., 2005). In contrast, we found here
that both sense and antisense SSOs can generate deletion
on plasmid and genomic DNA (Figs. 4 and 5). For plas-
mids, there was no obvious difference in deletion effi-
ciency between sense and antisense SSO treatment (Fig.
4A and 5A). However, when targeting genomic DNA,
antisense SSOs always showed a higher efficiency than
their sense counterparts (Fig. 4B and 5B).
We also tested whether phosphorothioate modification
can increase SSO-mediated deletion efficiency by pro-
tecting SSOs from DNA nuclease. Surprisingly, we
found that although efficiency was similar in HEK293
cells, in HeLa cells, modified SSOs exhibited a much
higher efficiency than unmodified ones (Fig. 6A and B).
This result was consistent in both plasmid and genome
based assays. As phosphorothioate modification func-
tions to protect SSOs against nucleases, we suggest that
the nuclease activity may vary among cell types, and the
effect of SSO modification might be determined by dif-
ferent DNA nuclease activity in different cell types.
DISCUSSION
In this study we successfully generated up to 1.6-kb
DNA fragment deletions in mammalian cells using
SSOs. We demonstrated that transfection of SSOs with
flanking homologous sequences could target homolo-
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FIG. 5. Effect of SSO length on deletion efficiency. (A) pSceGFP-24 and SSOs were cotransfected into HEK293 cells. (B)
HEK-24 cells were cotransfected with SSOs and I-SceI expression vector. Factors of sense (white) or antisense (black) of SSOs
were also tested. Data were derived from three independent experiments.
FIG. 6. Effect of SSO modification on deletion efficiency was influenced by cell type. SSOs with or without modification were
used to perform deletion assays on pSceGFP-24 in HeLa (empty) or HEK293 (filled) cells (A) or in HeLa-24 (white) or HEK-24
(black) cells with DSB induction (B). Data were derived from three independent experiments.
gous loci and cause deletions in both plasmid and ge-
nomic DNA. The deletion efficiency was about 0.2% for
plasmids, and up to 0.01% for chromosomal DNA.
In bacteria, SSOs can generate deletions very effi-
ciently with the aid of a -phage-encoded beta protein,
and the genetically modified bacteria can go through the
cell cycle and form colonies (unpublished data). How-
ever, in mammalian cells, although SSO-mediated dele-
tion can be achieved, the deletion efficiency is relatively
low. Furthermore, cells after chromosomal DNA deletion
cannot divide to form colonies, which is similar to cell
fate after SSO-mediated single-base substitution as pre-
viously reported (Olsen et al., 2005a; Wang et al., 2006).
We demonstrate here that this “survival” obstacle can be
overcome by introducing a DSB at the target site, which
results in viable cells following genomic DNA deletion
by SSOs. These results indicate that SSO-mediated dele-
tion uses a different mechanism in mammalian cells to
the bacterial recombineering system.
DSB also significantly increased SSO-mediated dele-
tion efficiency, and we demonstrated that this process de-
pends on the ATM/ATR kinases, similarly to DSB-in-
duced dsDNA-mediated repair. To our knowledge, in the
DSB-induced HRR process, the DNA terminates at the
original break-point are first digested by the DNA exonu-
clease, leaving single-stranded regions. Repair proteins
recruited to DSB can bind to these single-stranded ends
and facilitate pairing and strand exchange with their ho-
mologous counterparts. According to the current model,
the two single-stranded ends both pair to their homolo-
gous partners, synthesize new DNA sequence, separate
from the complex and fill the gap to complete the HRR
process (reviewed in Bartek et al., 2004). Here, we found
DSB can also be repaired using only SSO, suggesting
that repair of one end may be sufficient for the HRR pro-
cess. We prefer the model proposed by Storici et al.
(2006) that the SSO pairs to one single-strand overhang
at the break site and serves as a replication template. The
paired DNA overhang synthesizes new nucleotides,
which can pair to another overhang at the break site,
leading to completion of the HRR process.
In this report, we identified several factors that affect the
efficiency of SSO-mediated deletion repair. The efficiency
proved to be negatively related to deletion length, but posi-
tively related to SSO length. This result of SSO length was
expected, as in the HRR system increasing double-stranded
donor DNA length results in a higher recombination effi-
ciency (Bibikova et al., 2003). This is in contrast to the
SSO-mediated point mutation system without DSB induc-
tion, in which it was always the short SSOs around 25- to
45-mer long achieving the highest efficiency (Igoucheva et
al., 2001; Kenner et al., 2004; Olsen et al., 2005a, 2005b;
Yin et al., 2005), implying different mechanisms were used.
Strand bias is another factor previously identified to in-
fluence repair efficiency, as antisense SSOs always show
much higher efficiency than sense SSOs in repair assays
(Igoucheva et al., 2001, 2003; Yin et al., 2005). Here we
showed both sense and antisense SSO were able to
achieve successful deletion repair on plasmids with or
without DSB induction, and in genomic DNA with DSB
induction. There was no strand bias on plasmid repair,
but on genomic DNA, antisense SSOs always showed a
higher efficiency than sense SSOs.
We found SSO modification also influences repair ef-
ficiency, and this is related to cell type. In HeLa but not
HEK293 cells, modified SSOs showed significantly
higher efficiency than unmodified ones. As phosphoro-
thioate modifications protect SSO against nuclease
degradation, we suggest the nuclease activity varies
among cell types. Modified SSOs have always showed
much higher repair ability in previous reports (Igoucheva
et al., 2001; Yin et al., 2005). However, modified and un-
modified SSOs were reported to have similar efficiency
for mutagenesis in HEK293 cells (Radecke et al., 2004).
More research using various cell types is needed to con-
firm our hypothesis.
Concerning cell viability after chromosomal repair, we
found that cells can divide to form colonies after DSB-in-
duced repair by SSO, which implies that future wide-
spread application of this approach may be feasible. As
zinc-finger nuclease (ZFN) was reported to be a powerful
tool to generate DSB at prechosen sites in the genome
(Bibikova et al., 2003), we suggest that it may be possi-
ble to combine the SSO approach with ZFN to allow eas-
ier design and engineering of genomic DNA in mam-
malian cells.
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SUPPLEMENTAL DATA
SSO sequences:
Underlined nucleotides are with phosphorothioate modification.
M30as:
5-ATCGCCCTCGCCCTCGCCGGACACGCTGAA-3
M60as:
5-CTTGCCGTAGGTGGCATCGCCCTCGCCCTCGCCGGACACGCTGAACTTGTGGCCGTTTAC-3
M90as:
5-GAACTTCAGGGTCAGCTTGCCGTAGGTGGCATCGCCCTCGCCCTCGCCGGACACGCTGAACTTGTG-
GCCGTTTACGTCGCCGTCCAGCTC-3
90as:
5-GAACTTCAGGGTCAGCTTGCCGTAGGTGGCATCGCCCTCGCCCTCGCCGGACACGCTGAACTTGTG-
GCCGTTTACGTCGCCGTCCAGCTC-3
M30s:
5-TTCAGCGTGTCCGGCGAGGGCGAGGGCGAT-3
M60s:
5-GTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAG-3
M90s:
5-GAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCAC-
CTACGGCAAGCTGACCCTGAAGTTC-3
90s:
5-GAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCAC-
CTACGGCAAGCTGACCCTGAAGTTC-3
Control SSO:
E6:
5-CCTTGCTCACCATGGTGGCGGAATT-3
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FIG. S1. siRNAs efficiently silenced protein expression. Control siRNA, siATM, siATR, or siDNA-PKcs were transfected into
HEK-24 cells separately. Control experiment () indicated cells without transfection. Cells were collected at 48 hours after transfec-
tion. Immunobloting was performed to examine the targeted protein amount by using corresponding first antibodies: anti-ATM (A),
anti-ATR (B), and anti-DNA-PKcs (C), respectively. Anti--tubulin was used as an internal control to ensure the equal loading.
